Pinnacle Associates LTD Cytokinetics Inc Transaction History
Pinnacle Associates LTD
- $7.15 Billion
- Q3 2025
A detailed history of Pinnacle Associates LTD transactions in Cytokinetics Inc stock. As of the latest transaction made, Pinnacle Associates LTD holds 201,490 shares of CYTK stock, worth $13.4 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
201,490
Previous 208,527
3.37%
Holding current value
$13.4 Million
Previous $6.89 Million
60.73%
% of portfolio
0.15%
Previous 0.1%
Shares
34 transactions
Others Institutions Holding CYTK
# of Institutions
423Shares Held
129MCall Options Held
5.74MPut Options Held
1.37M-
T. Rowe Price Investment Management, Inc. Baltimore, MD19.1MShares$1.27 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$975 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$788 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.41MShares$492 Million0.07% of portfolio
-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct6MShares$399 Million0.17% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $6.25B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...